News >

Treatment Decisions Shifting in HER2+ Breast Cancer

Ellie Leick
Published: Tuesday, Jan 14, 2020

Erika P. Hamilton, MD, the director of the Breast Cancer Program at Sarah Cannon Research Institute

Erika P. Hamilton, MD
Research presented at the 2019 San Antonio Breast Cancer Symposium (SABCS) had a significant effect on the standard of care for patients with HER2-positive metastatic breast cancer, explained Erika P. Hamilton, MD.
... to read the full story
To Read the Full Story



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x